Monoclonal Antibodies to Detect SARS-CoV1 & SARS-CoV2
Monoclonal antibodies that cross bind to SARS-CoV1 & SARS-CoV2 and can therefore act as diagnostic or detection agents
Published: 14th April 2020

IP Status
- Provisional patent
Seeking
- Commercial partner
- Licensing